Haemonetics | HAE - Interest Expense On Debt


Haemonetics reported $5.08M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Baxter International USD 64M 14M Jun/2026
Becton, Dickinson and Co. USD 130M 2M Sep/2026
Boston Scientific USD 100M 4M Sep/2026
Cerus USD 2.33M 96K Jun/2024
Cooper Companies USD 21.5M 600K Jun/2026
Fresenius EUR 81M 5M Sep/2025
Fresenius Medical Care EUR 97.5M 14.5M Sep/2026
Globus Medical USD 5.53B 39.93M Sep/2026
Haemonetics USD 5.08M 2.32M Mar/2026
ICU Medical USD 18.56M 24K Jun/2026
Intuitive Surgical USD 19.35B 1.53B Sep/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 7.33M 4.78M Sep/2026
Neogen USD 13.8M 100K Jun/2026
OraSure Technologies 1.67M 1.13M Dec/2025
Plus Therapeutics USD 62K 25K Dec/2023
Quidel USD 5.78B 66M Sep/2026
ResMed USD 8.79M 14.55M Sep/2025
STAAR Surgical USD 900K 100K Jun/2026
Steris USD 11.2M 4.6M Sep/2026
Stryker USD 47.25B 683M Sep/2026
Teleflex USD 21.21M 6.75M Sep/2026
Terumo JPY 3.05B 1.58B Sep/2026
Thermo Fisher Scientific USD 417M 63M Sep/2026
US Physical Therapy USD 3.58M 370K Sep/2026
Zimmer Biomet Holdings USD 23.54B 740.8M Sep/2026